Summary The bacterial immunopotentiator OK-432 induced natural killer cell activating factor (NKAF) from mouse spleen cells. OK-432-induced NKAF showed a single peak with an apparent mol. wt of 70 Kd by Sephadex G-100 chromatography and OK-432-induced interleukin 2 (IL-2) had the same mol. wt as NKAF. However, OK-432-induced interferon (IFN) showed molecular heterogeneity with two peaks at 90Kd and 45 Kd. Further purification was achieved by Blue Sepharose affinity chromatography which copurified NKAF and IFN. The affinity-purified NKAF, however, was stable to heat (560C) and acid (pH 2) treatments. Moreover, anti-IFN failed to abolish NKAF activity and this activity was not absorbed by IL-2 dependent T cells. From isoelectric focusing analysis, a dissociation of NKAF and IFN was observed over the range of pl 6.5 to 8.0. Based on these results, KNAF appears to be a new kind of cytokine distinguishable from IFN and IL-2.
Lymphoid cells from many mammalian species exhibit spontaneous cell-mediated cytotoxicity against a variety of syngeneic, allogeneic and xenogeneic tumour target cells. The effector cells mediating spontaneous cytotoxicity have been designated natural killer (NK) cells, because of their natural tumoricidal capacity without any apparent presensitization (Pross et al., 1977) . There is strong evidence that NK cells infiltrate the tumour site (Flannery et al., 1981 ; Moore & Moore, 1979) and play a role in protection against tumour growth (Habu et al., 1981) , and against metastasis of transplantable tumours (Hanna, 1980; Talmadge et al., 1980) . NK cells also have the ability to kill freshly isolated autologous tumour cells (Uchida et al., 1983b) . Recently, substantial interest has been generated in soluble factors and agents which influence the level of NK cell-mediated cytotoxicity. Murine NK activity has been shown to be enhanced by a variety of immunoregulating substances such as interferon (Gidlund et al., 1978) , interleukin 2 (Henney et al., 1981) and thymic factor (Dominique et al., 1983) .
OK-432 is the one of the biological response modifiers which has been extensively used for malignant diseases. This agent has been found to enhance NK activity both in humans (Uchida & Mickshe, 1981) and in mice (Oshimi et al., 1980) . OK-432 also induces interleukin 2 (IL-2) and interferon (IFN) from human peripheral blood lymphocytes (Wakasugi et al., 1982) and IFN from mouse spleen cells (Saito et al., 1982) . In the murine system, however, spleen cell-derived NK cell activating factor induced by OK-432 stimulation has not been fully characterized. In order to investigate the factor most responsible for NK cell activation by we have studied the culture supernatants of OK-432-stimulated mouse spleen cells. As we report here, a soluble factor which demonstrates properties distinct from IFN and IL-2 plays an essential role in NK cell activation by OK- 432.
Materials and methods

Mice and tumour cells
Specific pathogen free BALB/c mice (6 to 8 weekold female) were obtained from Charles River Japan, Inc. (Atugi, Japan). YAC-1 lymphoma cells were used as NK target cells and L929 cells were used for IFN assay. YAC-1 cells were maintained in RPMI 1640 medium (GIBCO, Grand Island, NY) supplemented with 10% heat-inactivated foetal calf serum (FCS, GIBCO) and 60 ug ml-1 kanamycin (Meiji Seika Co., Ltd., Tokyo) . L929 cells were cultured in minimum essential medium (MEM, Nissui Co., Ltd., Tokyo) supplemented with 5% FCS. Sephadex G-100 chromatography Cell free supernatants were precipitated by 80% ammonium sulphate at 4°C for 24h. After centrifugation at 12,000g for 30min, the pellets were redissolved in 0.1 M PBS (pH 7.4) and dialyzed against the same buffer overnight at 4°C, then concentrated 100-fold from the starting supernatant volume by polyethylene glycol 20,000 (Wako Pure Chemical Ind., Osaka, Japan). Fifteen mililiters of concentrated materials (44mgml-1) were dialyzed against running buffer (0.1 M PBS, pH 7.4 containing 0.5 M NaCl and 0.02% NaN3), applied onto the Sephadex G-100 column (6 x 150 cm) and eluted in 14 ml fractions at a flow rate of 57.1 ml h-1. Then, 1 ml of each fraction was dialyzed against RPMI 1640 medium overnight, filtered and assayed for NKAF activity. Apparent mol. wt was estimated by comparison with the standard proteins: blue dextran (200 Kd), bovine serum albumin (BSA, 67 Kd) showed kinetically different NKAF production from that of Day-4 splenocytes, because untreated mouse splenocytes demonstrated levels of NKAF production at 24h of cultivation lower than those of 4-day splenocytes and higher levels of NKAF production after 48 h incubation. In contrast to NKAF production, both splenocyte preparations showed the same IFN production kinetics. IFN activity was detectable at 7 h after OK-432 stimulation, reached a plateau after 12h and remained unchanged for at least 48 h (Figure 2 ). Dose-dependent NKAF production in response to OK-432 stimulation To investigate the dose-dependency of NKAF production in response to OK-432 stimulation in vitro, the untreated mouse splenocytes and Day-4 splenocytes (107 cells ml-1 in 1% FCS-RPMI medium) were incubated with OK-432 (5 x 10-4, 5x 10-3 or 5 x 10-2KEml-1) or medium alone for 24 h. As shown in Figure 3 , Day 4 splenocytes showed levels of NKAF production higher than untreated mouse splenocytes at the concentration of 5 x10-3 and 5 x 10-2KEml-1. However active NKAF fractions (fr. 55-65) were collected and dialyzed against RPMI medium. Then the active materials were incubated with IL-2 dependent cells (104-107cellsml-P) at 4°C for 4h. After incubation, each supernatant was assayed for NKAF and IL-2 activity. As shown in Table I , NKAF activity remained unchanged even after incubation with IL-2 dependent cells. Before IL-2 absorption, the materials did not demonstrate any significant IL-2 activity in spite of the IL-2 peak fraction obtained by gel filtration. We observed that OK-432-induced IL-2 showed 10 or more times less activity than Con A-induced IL-2 in unseparated culture supernatants (Ichimura et al., 1983) and was liable to concentration and dialysis procedures (data not shown). Nevertheless NKAF activity was present in concentrate materials and was not absorbed by IL-2 dependent cells.
Blue Sepharose CL-6B affinity chromatography of Sephadex active NKAF IFNy can be selectively purified by Blue Sepharose affinity chromatography (Stefanos et al., 1980) . In order to remove IFNy from NKAF containing materials, Sephadex active NKAF fractions (fr. 55-65) were pooled, concentrated (38 mg ml-1), and loaded on to an affinity column. As shown in Figure 6 , NKAF and IFN were eluted in the same fraction by E3 buffer (1.5 M NaCl containing PBS). IL-2 activity was not observed in any fractions.
Stabilities of affinity-purified NKAF and the anti-IFN serum treatment To compare the physicochemical properties of NKAF and IFN, the affinity-purified NKAF fraction (fraction E3) was treated with heat (56°C, 30 min or 60 min) and acid (pH 2, 24 h). As shown in Table II Fraction number Figure 6 Blue Sepharose affinity chromatography of Sephadex G-100 active NKAF fraction. Sephadex G-100 active NKAF fraction (fr. 55-65) was prepared for chromatography on Blue Sepharose CL-6B. Absorbed materials were eluted with a discontinuous NaCl gradient (El buffer, 0.02M PBS, pH 7.4; E2 buffer, 0.2M NaCl PBS; E3 buffer, 1.5 M NaCl PBS; E4 buffer, 50% v/v ethylene glycol in E3 buffer). Each fraction was assayed for NKAF activity (0) and IFN activity (0) . NK activity incubated with medium alone was 10.8 +0.7 H. cAnti-IFN a/fi was equivalent to 100,000 neutralizing units ml-.
dAnti-IFN y was equivalent to 320 neutralizing units ml-'. Figure 8 , NKAF showed charge heterogeneity, with two major peaks (pl 4.0-6.0 and pl 6.5-8.0). Affinitypurified IFN, however, had an acidic pl 4. 0-6.0 only. These findings demonstrate that NKAF could be partially separated from IFN by IEF-PAGE.
Discussion
We found that an IL-2 and IFN-independent
30+
;n NKAF dilution Figure 7 In vitro augmentation of splenic and lymph node NK activity but not thymic NK activity by NKAF. Spleen, mesenteric lymph node and thymus cells were incubated with affinity purified NKAF (0.42 mgml-, with 1020 units ml-l of IFN activity) at various diluted concentrations as indicated in figure for 3 h prior to NK assay. NK activity of spleen (0) Isoelectric focusing PAGE of affinity-purified NKAF. Affinity-purified NKAF (fr. E3) was electrophoresed by IEF-PAGE as described in Materials and methods. Each fraction was assayed for NKAF activity (0) at an E :T ratio of 50:1 and for IFN activity (0) . NK activity incubated with medium alone was 10.7 + 1.5.
experiments: (i) the induction kinetics and the optimal concentration of OK-432 for the production of NKAF were different from those of IFN (Figures 2, 3 ) and single i.p. injection of OK-432 caused enhancement of NKAF production but not IFN in response to in vitro OK-432 stimulation (Figures 2, 3) . (ii) NKAF and OK-432-induced IL-2 demonstrated the same mol. wt 70 Kd, however, OK-432-induced IFN showed molecular heterogeneity by gel filtration analysis ( Figure 5 ). (iii) Although affinity-purified IFN was labile to heat (56°C) and acid (pH 2) treatments, NKAF was not affected by these treatments. Moreover, an additional anti-IFN antiserum treatment failed to abolish NKAF activity (Table II) . (iv) NKAF demonstrated charge heterogeneity in IEF-PAGE experiments. Furthermore, a dissociation of NKAF and IFN was observed over the pl range of 6.5 to 8.0 (Figure 8 ).
In the human system, Uchida et al. (1981) reported IL-2-and IFN-independent NK cell activation by OK-432. Their finding that anti-IFN serum failed to inhibit NK cell activation by OK-432 correlated well with our observations. In contrast to our present results, Wakasugi et al. (1982) reported the participation of IL-2 and IFN in NK cell activation by OK-432: IL-2, IFNcx and IFNy were induced in culture supernatants of OK-432-stimulated human peripheral lymphocytes. These discrepancies may result from differences in species, in the preparation of OK-432-stimulated culture supernatants, or in the time of pretreatment of effector cells (24h). We used the culture supernatant of OK-432-pretreated (Day-4) mouse splenocytes as a source of NKAF and employed a short term preincubation (3 h) system. According to Henney et al. (1981) , IL-2-induced boosting of NK activity is observed after 16h of culture. More than 6h of preincukation is required for recombinant IFNy-induced NK cell activation (John R. Ortaldo, personal communication) but not for recombinant IFNa, a protein which causes augmentation of NK activity, within hours (Herberman et al., 1982) . OK-432-induced IFN, copurified with NKAF, was gamma type because of its acid susceptibility and antigenicity (Table II) . These findings suggest that contaminating IFNy and IL-2 do not affect NKAF activity in a short term preincubation system; even so, we could not dismiss the possibility that contaminating IFNy and IL-2 may have altered the sensitivity of our effector cells to NKAF.
Although the cellular origin of NKAF remains unclear, our recent studies suggest that thymusderived lymphocytes may be the NKAF producer cells, because thymocytes produce NKAF-like factor in response to OK-432 stimulation in vitro. This factor resembles spleen-cell derived NKAF in terms of its chromatographic behaviour, but differs in terms of its antigenicity to IFN and IL-2, among other characteristics. I.p. administration of OK-432 prior to in vitro restimulation by OK-432 failed to augment IFN production but did augment NKAF production. These observations led us to suggest that a single injection of OK-432 is sufficient for NKAF induction but not for IFN induction and, furthermore, that the induction mechanisms might be different from each other. As previously reported, a single i.p. injection of OK-432 enhanced both interleukin 1 (IL-1) and IL-2 production in response to the in vitro rechallenge of OK-432 (Ichimura et al., 1983) . These interleukins may participate in NKAF production, since IL-1 augments IL-2 production and IL-2 regulates IFNy production by T cells (Farrar et al., 1982) .
The presence of NKAF throughout the cytotoxic assay resulted in higher levels of NK augmentation than did the absence of NKAF even after 24 h of preincubation (Table III) . NKAF did not demonstrate any direct cytotoxicity against YAC-1 target cells in a 4 h chromium release assay (data not shown). These observations suggest that NKAF might affect not only NKAF-responsive effector cells but also effector to target interaction or target susceptibility to NK cell-mediated cytolysis.
NKAF preparations augmented splenic and mesenteric lymph node NK cell activity in a dose dependent manner but not thymic NK cell activity (Figure 7 ). In the human system, OK-432 can activate peripheral blood and lymph node NK cell activity by in vitro stimulation. However, IFN failed to activate lymph node NK cell activity (Uchida et al., 1984) . Our preliminary observation that murine NKAF enhanced human peripheral blood NK cell activity (data not shown) led us to the speculation that the mechanisms of NKAFinduced NK cell activation might be different from those of IFN-induced NK cell activation which is a well documented species-specific phenomenon (Heron et al., 1979; Herberman et al., 1982) .
In human cancer patients, intrapleural administration of OK-432 resulted in an induction or augmentation of effusion NK cell activity along with reduction or disappearance of effusion tumour cells. Autologous tumour killer cells induced by OK-432 demonstrated NK cell morphological characteristics (Uchida et al., 1983a) . These clinical findings suggest that NK cell activation is most responsible for the anti-tumour effect of OK-432.
In conclusion, our observations indicate that the regulation of mouse NK activity in vitro is complex and subject to the participation of NKAF as well as IFN and IL-2 in OK-432 stimulation. These findings provide the basis for future studies on the modulation of NK activity.
